Every year, hundreds of promising basic discoveries in the pharmacological field are lost and will never have a chance to be exploited for patients due to difficulties in clinical translation. This is especially true for most neurodegenerative disorders lacking disease-modifying therapies. Here we present the current scenario and our vision of a 'collective-impact' multistakeholder approach to expedite the development of new drugs.
Nonprofit foundations spur translational research / P. Zaratin, M.A. Battaglia, M.P. Abbracchio. - In: TRENDS IN PHARMACOLOGICAL SCIENCES. - ISSN 0165-6147. - 35:11(2014), pp. 552-555. [10.1016/j.tips.2014.09.003]
Nonprofit foundations spur translational research
M.P. AbbracchioUltimo
2014
Abstract
Every year, hundreds of promising basic discoveries in the pharmacological field are lost and will never have a chance to be exploited for patients due to difficulties in clinical translation. This is especially true for most neurodegenerative disorders lacking disease-modifying therapies. Here we present the current scenario and our vision of a 'collective-impact' multistakeholder approach to expedite the development of new drugs.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Zaratin_2014.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
307.37 kB
Formato
Adobe PDF
|
307.37 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
